Ki Sook Park

This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Lg Life Sciences, Limited, Lg Chemical Ltd., Lg Chem, Ltd. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ki Sook Park. Retrieved from https://idiyas.com/inventor/ki-sook-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 87.5

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 38(Granted Patents)

Location History:

Daejon, KR (1999)
Daejeon, KR (1998 - 2014)

Company Filing History:

4 out of 75

Lg Life Sciences, Limited

Years Active: 1998-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12661349 - Pharmaceutically acceptable salt of sphingosine-1-phosphate receptor agonist, and crystalline form thereof (2026-06-23),

2. 8859567 - Hydrate of 1-{(2S)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di-hydropyrido[3,4-D]pyrimidin-7(6H)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate (2014-10-14),

3. 8044080 - Isoxazoline derivative and novel process for its preparation (2011-10-25),

4. 7700617 - Salt of naphthyridine carboxylic acid derivative (2010-04-20),

5. 6723734 - Salt of naphthyridine carboxylic acid derivative (2004-04-20),

6. 5962468 - 7-(4-aminomethyl-3-methyloxyiminopyrrolidin-1-yl)-1- (1999-10-05),

7. 5869670 - 7-(4-aminomethyl-3-me (1999-02-09),

8. 5776944 - 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu (1998-07-07),

Title: Ki Sook Park: Innovator in Pharmaceutical Chemistry

Introduction

Ki Sook Park is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 8 patents. Her work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Among her latest patents is the invention titled "Hydrate of 1-{(2S)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di-hydropyrido[3,4-D]pyrimidin-7(6H)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate." This invention relates to a 1.5 hydrate of the compound, a process for preparing it, and a pharmaceutical composition for inhibiting DPP-IV, which includes this compound as the active component. Another notable patent is for an "Isoxazoline derivative and novel process for its preparation." This invention involves an isoxazoline derivative that has the cyclic carboxylic acid hemiketal moiety for use as a caspase inhibitor, along with a process for its preparation and a pharmaceutical composition comprising it.

Career Highlights

Ki Sook Park has worked with notable companies such as LG Life Sciences and LG Chem Ltd. Her experience in these organizations has allowed her to develop her expertise in pharmaceutical innovations and contribute to various research projects.

Collaborations

Throughout her career, Ki Sook Park has collaborated with esteemed colleagues, including Jay Hyok Chang and Hoon Moo Choi. These collaborations have further enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Ki Sook Park is a distinguished inventor whose work in pharmaceutical chemistry has led to several important patents. Her contributions continue to impact the industry positively, showcasing her dedication to innovation and research.

Profile summary based on public USPTO records.